These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2003204)

  • 21. FDA implementation of standards developed by the International Conference on Harmonisation.
    Booth PM
    Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561
    [No Abstract]   [Full Text] [Related]  

  • 22. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The FDA and the fight against terrorism.
    Meadows M
    FDA Consum; 2004; 38(1):20-7. PubMed ID: 15032200
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA issues guidelines for biosimilar drugs.
    Cancer Discov; 2012 Mar; 2(3):196. PubMed ID: 22585973
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA-USP drug product problem reporting program--an update.
    Wheatley LS
    Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
    [No Abstract]   [Full Text] [Related]  

  • 26. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 27. Investigation of new drugs.
    Holsten DW; Weilerstein R
    Hospitals; 1972 Mar; 46(6):97-104. PubMed ID: 5009178
    [No Abstract]   [Full Text] [Related]  

  • 28. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 29. The FDA advances scientific research.
    FDA Consum; 2006; 40(2):5. PubMed ID: 16673452
    [No Abstract]   [Full Text] [Related]  

  • 30. The FDA and Helsinki.
    Rennie S
    Hastings Cent Rep; 2009; 39(3):49. PubMed ID: 19537622
    [No Abstract]   [Full Text] [Related]  

  • 31. New drugs: the AMA and FDA roles.
    Appel JZ
    J Ark Med Soc; 1966 Jul; 63(2):67-9. PubMed ID: 4223555
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA urged to establish "provisional approval" system for new drugs.
    Odne MA; Jeffrey LP
    Hosp Formul; 1976 Jul; 11(7):346. PubMed ID: 1026691
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 34. How good are our drugs?
    Miller LC
    Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
    [No Abstract]   [Full Text] [Related]  

  • 35. Stability analysis for drugs with multiple active ingredients.
    Chow SC; Shao J
    Stat Med; 2007 Mar; 26(7):1512-7. PubMed ID: 16955533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new fear factor: hazardous drugs revealed.
    Cassidy B
    Geriatr Nurs; 2005; 26(5):276-8. PubMed ID: 16213978
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopical contaminant monitoring. I. Particulate matter as viewed by the FDA.
    Schwartzman G
    Bull Parenter Drug Assoc; 1977; 31(4):161-5. PubMed ID: 890178
    [No Abstract]   [Full Text] [Related]  

  • 39. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 40. Sterility requirement for aqueous-based drug products for oral inhalation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 May; 65(103):34082-9. PubMed ID: 11010719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.